BBK Worldwide Shows Off Scalable Mobile App Platform for Optimized Study Community Engagement

On Monday, mHealthWatch learned that BBK Worldwide, a leader in patient recruitment and engagement technologies and services, is rolling out major updates to its mobile app platform.

“Powered by TrialCentralNet, the only Patient Recruitment Management System (PRMS) of its kind, the comprehensive mobile app platform allows any clinical research or healthcare organization, including sponsors, CROs, and advocacy groups, to develop and utilize custom mobile apps in weeks instead of months, and at a small fraction of the cost of in-house development,” a provided statement emailed to MHW reads.

We’re told that BBK developed the mobile app platform from the ground up expressly for clinical teams interested in leveraging the power of mobile apps to deliver a customized user experience and according to the needs of a specific study and patient community.

Highly scalable, the BBK platform can be leveraged for six sites or 60, in dozens of languages and countries, and offer a variety of feature options for prescreening, study guidelines and study visit schedules. What’s more, by utilizing BBK’s comprehensive configuration model, sponsors and CROs can support sites and study teams confidently knowing that they’re delivering all study materials and communications via the industry’s most reliable, scalable cloud-based recruitment system.

“Clinical teams are very interested in utilizing mobile apps within their studies — yet they also understand that it’s resource intensive and cost prohibitive to develop custom patient- and site-facing apps in-house,” said Erica Mercado, BBK’s VP of Market Innovation and Product Expansion. “We developed a highly scalable platform that allows clinical teams to blend custom user experiences with study management efficiency — making it possible for studies of all sizes to leverage the power of mobile. It’s a win-win.”

To learn more about the platform and what’s new, click here.

This post was written by:

- who has written 2292 posts on mHealthWatch.

Contact the author